| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 2972362 | The Journal of Heart and Lung Transplantation | 2009 | 7 Pages |
Abstract
Infants supported with ECMO are at low risk for HLA sensitization. Because it provides full antibody specificity disclosure, Luminex complements more conventional PRA assays by quantitatively identifying potential donor-specific antibodies, which should facilitate the virtual crossmatch process, thereby minimizing post-HTx humoral rejection risk.
Related Topics
Health Sciences
Medicine and Dentistry
Cardiology and Cardiovascular Medicine
Authors
Jeremy BA, Cynthia BA, Doug MD, PhD, Lisa BA, Mary PCNP, Karen BS, Robert MD,